These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 9010110)
41. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer. Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578 [TBL] [Abstract][Full Text] [Related]
42. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application]. Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141 [TBL] [Abstract][Full Text] [Related]
43. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer. Dikmen E; Kara M; Dikmen G; Cakmak H; Dogan P Eur J Cardiothorac Surg; 2003 Feb; 23(2):194-9; discussion 199-20. PubMed ID: 12559342 [TBL] [Abstract][Full Text] [Related]
44. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]. Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Xinarianos G; Scott FM; Liloglou T; Prime W; Turnbull L; Walshaw M; Field JK Lung Cancer; 2000 Apr; 28(1):37-42. PubMed ID: 10704707 [TBL] [Abstract][Full Text] [Related]
46. Telomerase activity in patients with transitional cell carcinoma: a preliminary study. Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771 [TBL] [Abstract][Full Text] [Related]
47. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients. Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274 [TBL] [Abstract][Full Text] [Related]
48. Detection of telomerase activity in breast masses by fine-needle aspiration. Pearson AS; Gollahon LS; O'Neal NC; Saboorian H; Shay JW; Fahey TJ Ann Surg Oncol; 1998 Mar; 5(2):186-93. PubMed ID: 9527273 [TBL] [Abstract][Full Text] [Related]
49. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Bian W; Xu Z Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565 [TBL] [Abstract][Full Text] [Related]
50. Telomerase detection in body fluids. Hess JL; Highsmith WE Clin Chem; 2002 Jan; 48(1):18-24. PubMed ID: 11751534 [TBL] [Abstract][Full Text] [Related]
51. Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients. Casadio V; Bravaccini S; Gunelli R; Nanni O; Zoli W; Amadori D; Calistri D; Silvestrini R Int J Biol Markers; 2009; 24(4):253-7. PubMed ID: 20082275 [TBL] [Abstract][Full Text] [Related]
52. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection. Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713 [TBL] [Abstract][Full Text] [Related]
53. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302 [TBL] [Abstract][Full Text] [Related]
54. [Detection of telomerase activity of exfoliated cells in bile and its clinical impact]. Yu SA; Peng CH; Wu RJ; Zheng ZD; Chen K; Fu ZN Ai Zheng; 2002 Feb; 21(2):177-80. PubMed ID: 12479071 [TBL] [Abstract][Full Text] [Related]
55. Telomerase activity in small-cell and non-small-cell lung cancers. Hiyama K; Hiyama E; Ishioka S; Yamakido M; Inai K; Gazdar AF; Piatyszek MA; Shay JW J Natl Cancer Inst; 1995 Jun; 87(12):895-902. PubMed ID: 7666478 [TBL] [Abstract][Full Text] [Related]
56. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746 [TBL] [Abstract][Full Text] [Related]
57. Telomerase activity in malignant and benign bladder conditions. Mayfield MP; Shah T; Flannigan GM; Hamilton Stewart PA; Bibby MC Int J Mol Med; 1998 May; 1(5):835-40. PubMed ID: 9852304 [TBL] [Abstract][Full Text] [Related]
58. Telomerase activity in human proliferative breast lesions. Poremba C; Böcker W; Willenbring H; Schäfer KL; Otterbach F; Bürger H; Diallo R; Dockhorn-Dworniczak B Int J Oncol; 1998 Mar; 12(3):641-8. PubMed ID: 9472105 [TBL] [Abstract][Full Text] [Related]
59. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise. Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230 [TBL] [Abstract][Full Text] [Related]